The age of onset of tumor formation in human p53 mutation carriers has been shown to be modified in four independent studies by a high frequency single nucleotide polymorphism in the promoter of the Mdm2 oncogene (MDM2 SNP309, T/G) [6]-[9]. The gene discussed is MDM2; the disease is neoplasm.